COX-2 억제제가 누드마우스에 이식된 위암세포주에서 종양의 성장과 전이에미치는 영향
The Effect of COX-2 Inhibitor on the Growth and Metastasis of Gastric CancerXenograft
오정식, 심우정, 차성재, 지경천, 박성준, 임현묵, 박성일, 이태진, 박언섭,
소속 상세정보
오정식 ( Oh Joung-Sik )
중앙대학교 의과대학 외과학교실
심우정 ( Sim Woo-Jung )
중앙대학교 의과대학 외과학교실
차성재 ( Cha Sung-Jae )
중앙대학교 의과대학 외과학교실
지경천 ( Chi Kyong-Chon )
중앙대학교 의과대학 외과학교실
박성준 ( Park Sung-Jun )
중앙대학교 의과대학 외과학교실
임현묵 ( Lim Hyun-Muk )
중앙대학교 의과대학 외과학교실
박성일 ( Park Sung-Il )
중앙대학교 의과대학 외과학교실
이태진 ( Lee Tae-Jin )
중앙대학교 의과대학 병리학교실
박언섭 ( Park Eon-Sub )
중앙대학교 의과대학 병리학교실
KMID : 0371320020620020095
Abstract
Purpose: Tumor invasion and metastasis are known to be extremely
important factors in the prognosis of cancer patients. Although recent
studies have demonstrated that cyclooxygenase-2 (COX-2) is overexpressed in
various cancers including gastric cancer, the mechanisms underlying the
contribution of COX-2 to tumorigenesis and tumor promotion remain unclear.
Methods: In order to determine the role of COX-2 in tumor growth and
metastasis, we investigated COX-2 expression, apoptosis and the expression
of E-cadherin, CD44v6, MMP-2 and TIMP-2 in gastric cancer xenografts treated
with meloxicam (a selective COX-2 inhibitor). Results: Cells from the
MKN45 gastric cancer cell line that overexpress COX-2 were inoculated
subcutaneously into athymic mice. Oral administration with meloxicam reduced
the tumor volume (P<0.01), induced apoptosis of cancer cells (P<0.01),
suppressed the proliferation rates (P<0.01), increased the expression of
E-cadhrin (P<0.05) and reduced the expression of MMP-2 and TIMP-2.
Conclusion: The above data showed that COX-2 inhibitors can inhibit
tumor growth and suppress metastatic potential by expression of adhesion
molecules and suppression of metalloproteinases, suggesting that this
inhibitor can be used as an additive anti-cancer drug in cases of stomach
cancer with radical resection, although further evaluation is required.
키워드
COX-2; 위암; 종양의 성장; 전이; COX-2; Gastric cancer; Tumor growth; Metastasis;
원문 및 링크아웃 정보
등재저널 정보